Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Apollo Healthcare Corp Warrants (03/01/2022) APHWF

Based in Ontario Canada the Apollo Healthcare Corp Apollo is one of the largest private label personal care product manufacturers in North America developing and manufacturing retailer branded and private label products for major North American retailers. Apollos products are sold in tens of thousands of stores across North America and its customer base spans across major North American grocery drug and mass merchandise retailers users as well as wholesale clubs. In addition to private label Apollo also manufactures products on a contract basis for many of its clients.


OTCPK:APHWF - Post by User

Post by laurencelefouon Mar 16, 2021 8:22am
315 Views
Post# 32805982

Covid-19

Covid-19 Until yesterday, I had never heard of Apollo healthcare.  Saw the news about Fourth Quarter 2020 results.  Talk about modesty, year over year revenues are up 92% and Apollo makes no reference to what caused the increase.  Found the answer in the August 11, 2020, press release  ''the Company augmented existing customer demand and attracted new customers for its cleanser and sanitizer products.''   The increase in revenues is partially the result of Covid-19.
 
I am impressed by the FY 2020 financial statements.  Thirty-one million dollars in cash and no debt, revenues of $321.7 million, operating cash flows (OCF) of  $108.7 million, resulting in a 34% margin ($108.7 / $321.7).  Revenues for the past three quarters have declined but operating cash flows have increased.  For the past two quarters OCF / revenue yields were above 40%.  That ratio is better than most tech stocks.    Market cap is ±$340 million.  It is cheap real cheap.  Why is it cheap???
 
1)            Apollo's operating cash flows were boosted by not paying taxes (page 5 MDA).  Revenues for the past three quarters have declined.
 
2)            Apollo is one of the largest private label personal care product manufacturers in North America, not exactly a high growth sector of the economy, but with the right product mix Apollo has shown it can be a highly profitable business.
 
3)            FY 2021 will likely be the reverse mirror image of 2020.  As the Covid-19 crisis subsides, Q4 2021 revenues will likely be lower than Q1 2021.  Long-term investors are asking themselves, will the revenue growth rate for 2022 look like 2020 and 2021 or look like 2019, 2018, 2017?  Or perhaps something in between.  When Covid-19 dies off, by how much will customers reduce their purchase of cleanser and sanitizer products?
 
4)            Customer risk.  As of December 2019, two clients represented 71% of revenues.  As of December 2020, three clients represented 70% of revenues. (Note 12)

Just read the December 2020 Smallcappower article.  Apollo has many great customers, Walmart, Loblaws, Costco, Target, Shoppers, CVS.  The author makes several good points.  

As a value investor and bargain hunter, Apollo Healthcare current valuation offers good upside possibilities and limited downside protection.

  
https://smallcappower.com/expert-articles/apollo-healthcare-canadian-manufacturing-stock/

<< Previous
Bullboard Posts
Next >>